Enalare Therapeutics Inc.
PrivateLast Round
Grant
Jan 30, 2025
Total Funding Raised
$45.27M
Momentum Score
25 /100
Company Overview
Enalare Therapeutics Inc. is a biopharmaceutical company that develops and commercializes novel therapies for patients suffering from life-threatening acute respiratory and critical care conditions, including respiratory depression caused by drug overdose, post-surgery, and other conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enalare Therapeutics Inc. Comps
Public and private peers based on sector, stage, and business model.
Enalare Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 30, 2025 | ||||
| Grant | Sep 10, 2024 | ||||
| Grant | Sep 27, 2022 | ||||
| Series A | Aug 9, 2022 | ||||
| Grant | Jul 1, 2022 | ||||
Seed | Feb 2, 2021 |
Enalare Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biomedical Advanced Research and Development Authority | Grant |
| National Institute on Drug Abuse | Grant |
Enalare Therapeutics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enalare Therapeutics Inc.'s valuation, stock price, and market status.
